Clinical Trial Update: A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Stage 2B or 3 Locally Advanced, Colon Cancer [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update describing a study of palifermin (brand Kepivance) to reduce oral mucositis in patients with stage 2B/3 locally advanced colon cancer (Pha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Drugs mentioned

• Kepivance (Palifermin)

Snippet

Sponsor: Amgen | Conditions: Colon Cancer | Phase 2, Phase 3 | Status: COMPLETED